Les Sulewski
Stock Analyst at Truist Financial
(4.22)
# 1,397
Out of 4,495 analysts
185
Total ratings
53.1%
Success rate
11.5%
Average return
Main Sectors:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRMD CorMedix | Maintained: Buy | n/a | $8.67 | - | 23 | May 15, 2026 | |
| COLL Collegium Pharmaceutical | Maintained: Buy | n/a | $35.81 | - | 20 | May 14, 2026 | |
| ANIP ANI Pharmaceuticals | Maintained: Hold | n/a | $83.78 | - | 25 | May 11, 2026 | |
| VTRS Viatris | Reiterated: Buy | $20 | $16.34 | +22.40% | 8 | May 8, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintained: Buy | $18 | $6.38 | +182.13% | 4 | May 7, 2026 | |
| PCRX Pacira BioSciences | Maintained: Buy | n/a | $25.50 | - | 24 | May 1, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | n/a | $6.88 | - | 18 | May 1, 2026 | |
| TEVA Teva Pharmaceutical Industries | Rated: Buy | $42 → $45 | $33.10 | +35.95% | 11 | Apr 30, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintained: Buy | n/a | $17.02 | - | 21 | Apr 23, 2026 | |
| BTMD biote | Maintained: Buy | $5 → $4 | $2.28 | +75.44% | 19 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €22.00 | $27.84 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $102.81 | n/a | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24.06 → $19.81 | $18.15 | n/a | 5 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.4275 | n/a | 5 | Jul 9, 2024 |
CorMedix
May 15, 2026
Maintained: Buy
Price Target: n/a
Current: $8.67
Upside: -
Collegium Pharmaceutical
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $35.81
Upside: -
ANI Pharmaceuticals
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $83.78
Upside: -
Viatris
May 8, 2026
Reiterated: Buy
Price Target: $20
Current: $16.34
Upside: +22.40%
Vanda Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $18
Current: $6.38
Upside: +182.13%
Pacira BioSciences
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $25.50
Upside: -
Bausch Health Companies Inc.
May 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.88
Upside: -
Teva Pharmaceutical Industries
Apr 30, 2026
Rated: Buy
Price Target: $42 → $45
Current: $33.10
Upside: +35.95%
Amneal Pharmaceuticals
Apr 23, 2026
Maintained: Buy
Price Target: n/a
Current: $17.02
Upside: -
biote
Apr 16, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $2.28
Upside: +75.44%
May 27, 2025
Initiated Coverage: Buy
Price Target: €22.00
Current: $27.84
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $102.81
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $24.06 → $19.81
Current: $18.15
Upside: n/a
Jul 9, 2024
Rated: Hold
Price Target: n/a
Current: $0.4275
Upside: n/a